Goldman Sachs’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17M | Buy |
122,300
+74,700
| +157% | +$10.5M | ﹤0.01% | 2586 |
|
|
2025
Q4 | $5.84M | Buy |
47,600
+19,600
| +70% | +$2.38M | ﹤0.01% | 3602 |
|
|
2025
Q3 | $3.11M | Buy |
28,000
+19,000
| +211% | +$2.16M | ﹤0.01% | 4077 |
|
|
2025
Q2 | $998K | Buy |
+9,000
| New | +$958K | ﹤0.01% | 4707 |
|
|
2025
Q1 | – | Sell |
-10,000
| Closed | -$924K | – | 6194 |
|
|
2024
Q4 | $924K | Hold |
10,000
| – | – | ﹤0.01% | 4876 |
|
|
2024
Q3 | $838K | Sell |
10,000
-30,000
| -75% | -$2.29M | ﹤0.01% | 4759 |
|
|
2024
Q2 | $2.74M | Hold |
40,000
| – | – | ﹤0.01% | 3685 |
|
|
2024
Q1 | $2.93M | Buy |
40,000
+9,200
| +30% | +$707K | ﹤0.01% | 3557 |
|
|
2023
Q4 | $2.5M | Sell |
30,800
-32,500
| -51% | -$2.53M | ﹤0.01% | 3753 |
|
|
2023
Q3 | $4.74M | Sell |
63,300
-41,400
| -40% | -$3.18M | ﹤0.01% | 3023 |
|
|
2023
Q2 | $8.07M | Sell |
104,700
-80,100
| -43% | -$6.39M | ﹤0.01% | 2659 |
|
|
2023
Q1 | $15.3M | Buy |
184,800
+60,200
| +48% | +$4.99M | ﹤0.01% | 2040 |
|
|
2022
Q4 | $10.7M | Buy |
124,600
+100,300
| +413% | +$7.94M | ﹤0.01% | 2519 |
|
|
2022
Q3 | $1.5M | Sell |
24,300
-1,600
| -6% | -$101K | ﹤0.01% | 4210 |
|
|
2022
Q2 | $1.6M | Sell |
25,900
-64,600
| -71% | -$4M | ﹤0.01% | 4234 |
|
|
2022
Q1 | $5.38M | Sell |
90,500
-224,400
| -71% | -$14.3M | ﹤0.01% | 3286 |
|
|
2021
Q4 | $22.9M | Buy |
314,900
+148,400
| +89% | +$10.2M | ﹤0.01% | 1997 |
|
|
2021
Q3 | $11.6M | Sell |
166,500
-318,500
| -66% | -$22.4M | ﹤0.01% | 2580 |
|
|
2021
Q2 | $33.4M | Buy |
485,000
+185,100
| +62% | +$12.4M | 0.01% | 1617 |
|
|
2021
Q1 | $19.4M | Sell |
299,900
-272,100
| -48% | -$17.5M | ﹤0.01% | 1957 |
|
|
2020
Q4 | $33.3M | Buy |
572,000
+137,900
| +32% | +$8.32M | 0.01% | 1449 |
|
|
2020
Q3 | $27.4M | Buy |
434,100
+253,400
| +140% | +$17.6M | 0.01% | 1489 |
|
|
2020
Q2 | $13.9M | Sell |
180,700
-456,300
| -72% | -$35M | ﹤0.01% | 1984 |
|
|
2020
Q1 | $47.6M | Buy |
637,000
+441,100
| +225% | +$30.5M | 0.02% | 898 |
|
|
2019
Q4 | $12.7M | Sell |
195,900
-83,400
| -30% | -$5.43M | ﹤0.01% | 2249 |
|
|
2019
Q3 | $17.7M | Sell |
279,300
-174,100
| -38% | -$11.4M | 0.01% | 1877 |
|
|
2019
Q2 | $30.6M | Buy |
453,400
+78,900
| +21% | +$5.19M | 0.01% | 1517 |
|
|
2019
Q1 | $24.3M | Buy |
374,500
+61,100
| +19% | +$4.06M | 0.01% | 1712 |
|
|
2018
Q4 | $19.6M | Sell |
313,400
-33,300
| -10% | -$2.33M | 0.01% | 1823 |
|
|
2018
Q3 | $26.8M | Sell |
346,700
-351,200
| -50% | -$26.5M | 0.01% | 1704 |
|
|
2018
Q2 | $49.4M | Sell |
697,900
-18,700
| -3% | -$1.32M | 0.01% | 1217 |
|
|
2018
Q1 | $54M | Sell |
716,600
-457,200
| -39% | -$36.3M | 0.01% | 1141 |
|
|
2017
Q4 | $84.1M | Buy |
1,173,800
+21,500
| +2% | +$1.63M | 0.02% | 912 |
|
|
2017
Q3 | $93.4M | Sell |
1,152,300
-317,600
| -22% | -$24.3M | 0.02% | 857 |
|
|
2017
Q2 | $104M | Buy |
1,469,900
+559,200
| +61% | +$37.2M | 0.03% | 735 |
|
|
2017
Q1 | $61.9M | Sell |
910,700
-123,700
| -12% | -$8.7M | 0.02% | 1081 |
|
|
2016
Q4 | $74.1M | Sell |
1,034,400
-137,100
| -12% | -$10.2M | 0.02% | 986 |
|
|
2016
Q3 | $92.7M | Sell |
1,171,500
-104,000
| -8% | -$8.45M | 0.03% | 761 |
|
|
2016
Q2 | $106M | Buy |
1,275,500
+387,900
| +44% | +$34.4M | 0.03% | 633 |
|
|
2016
Q1 | $81.5M | Sell |
887,600
-476,700
| -35% | -$43M | 0.03% | 771 |
|
|
2015
Q4 | $138M | Sell |
1,364,300
-1,194,000
| -47% | -$124M | 0.04% | 508 |
|
|
2015
Q3 | $251M | Buy |
2,558,300
+1,658,700
| +184% | +$184M | 0.08% | 235 |
|
|
2015
Q2 | $105M | Sell |
899,600
-1,281,300
| -59% | -$140M | 0.03% | 633 |
|
|
2015
Q1 | $214M | Buy |
2,180,900
+308,300
| +16% | +$31.3M | 0.07% | 331 |
|
|
2014
Q4 | $177M | Buy |
1,872,600
+785,800
| +72% | +$81.3M | 0.06% | 410 |
|
|
2014
Q3 | $116M | Sell |
1,086,800
-267,800
| -20% | -$26.2M | 0.04% | 568 |
|
|
2014
Q2 | $112M | Sell |
1,354,600
-2,887,900
| -68% | -$225M | 0.04% | 608 |
|
|
2014
Q1 | $301M | Buy |
4,242,500
+1,908,200
| +82% | +$150M | 0.1% | 203 |
|
|
2013
Q4 | $175M | Buy |
2,334,300
+438,500
| +23% | +$30.5M | 0.06% | 394 |
|
|
2013
Q3 | $119M | Sell |
1,895,800
-487,400
| -20% | -$29.1M | 0.04% | 514 |
|
|
2013
Q2 | $122M | Buy |
+2,383,200
| New | +$124M | 0.05% | 458 |
|
Other funds holding GILD
VCM
VPM
Goldman Sachs's GILD Position: Q1 2026 in Review
Goldman Sachs increased its Gilead Sciences (GILD) stake by 26% in Q1 2026, buying an estimated $324M and bringing the position to 11,065,214 shares worth $1.54B. The position accounts for 0.18% of the portfolio, ranked #93.
Goldman Sachs first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.35B in Q2 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Goldman Sachs held 11,065,214 shares of Gilead Sciences worth $1.54B as of Q1 2026.
- Goldman Sachs bought 2,312,701 Gilead Sciences shares in Q1 2026, an estimated $324M.
- Gilead Sciences made up 0.18% of Goldman Sachs's portfolio in Q1 2026, its #93 holding.
- Goldman Sachs first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Gilead Sciences position peaked at $2.35B in Q2 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.